Association between PIP4K2A polymorphisms and acute lymphoblastic leukemia susceptibility

Medicine (United States)

Volumn 95, Issue 18, 2016, Pages e3542-

  Liao, Fei ^a   Yin, Dandan ^a   Zhang, Yan ^a   Hou, Qianqian ^a   Zheng, Zhaoyue ^a   Yang, Li ^a   Shu, Yang ^a   Xu, Heng ^a   Li, Yu ^b  

^a SICHUAN UNIVERSITY   (China)

^b First People's Hospital of Lianyungang   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 5 PHOSPHATE 4 KINASE TYPE 2 ALPHA; PHOSPHATIDYLINOSITOL KINASE; UNCLASSIFIED DRUG; PHOSPHOTRANSFERASE; PIP4K2A PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; AFRICAN AMERICAN; ARTICLE; ASIAN; BINDING AFFINITY; CAUCASIAN; CNKI DATABASE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HISPANIC; HUMAN; LYMPHOCYTE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; MALE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84969835770     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003542     Document Type: Article

References (32)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166-178.
2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030-1043.
3. Trevino LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1001-1005.
4. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1006-1010.
5. Xu H, Yang W, Perez-Andreu V, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Institute. 2013;105:733-742.
6. Perez-Andreu V, Roberts KG, Harvey RC, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet. 2013;45:1494-1498.
7. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42:492-494.
8. Xu H, Zhang H, Yang W, et al. Inherited coDing variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nature Commun. 2015;6:7553.
9. Perez-Andreu V, Roberts KG, Xu H, et al. A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. Blood. 2015;125:680-686.
10. Migliorini G, Fiege B, Hosking FJ, et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood. 2013;122:3298-3307.
11. Walsh KM, de Smith AJ, Chokkalingam AP, et al. Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype. Blood. 2013;121:4808-4809.
12. Prasad RB, Hosking FJ, Vijayakrishnan J, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor Bcell acute lymphoblastic leukemia of childhood. Blood. 2010;115:1765-1767.
13. Yang W, Trevino LR, Yang JJ, et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia. 2010;24:894-896.
14. Deng J, Xue Y, Wang Y, et al. 10p12.31-12.2 variants and risk of childhood acute lymphoblastic leukemia in a Chinese population. Leukem Lymph. 2015;56:175-178.
15. Wang Y, Chen J, Li J, et al. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. Gene. 2013;524:203-207.
16. Guo LM, Xi JS, Ma Y, et al. ARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a metaanalysis based on 39,116 subjects. Tumour Biol. 2014;35:709-713.
17. Li S, Ren L, Fan L, et al. IKZF1 rs4132601 polymorphism and acute lymphoblastic leukemia susceptibility: a meta-analysis. Leukem Lymph. 2015;56:978-982.
18. Wang C, Chen J, Sun H, et al. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a metaanalysis of 11 case-control studies with 5,639 cases and 10,036 controls. Ann Hematol. 2015;94:181-185.
19. Xu H, Cheng C, Devidas M, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2012;30:751-757.
20. Lopez-Lopez E, Gutierrez-Camino A, Martin-Guerrero I, et al. Re: novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Institute. 2013;105:1512-1513.
21. Perez-Andreu V, Xu H, Yang JJ. The novel susceptibility variants for childhood acute lymphoblastic leukemia. J Natl Cancer Institute. 2013;105:1512-1513.
22. Freedman ML, Monteiro AN, Gayther SA, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet. 2011;43:513-518.
23. Fiume R, Stijf-Bultsma Y, Shah ZH, et al. PIP4K and the role of nuclear phosphoinositides in tumour suppression. Biochim Biophys Acta. 2015;1851:898-910.
24. Zhang W, Duan S, Kistner EO, et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Human Genet. 2008;82:631-640.
25. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120-132.
26. Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucl Acids Res. 2015.
27. Zhou X, Maricque B, Xie M, et al. The human epigenome browser at Washington University. Nature Meth. 2011;8:989-990.
28. Bauer DE, Kamran SC, Lessard S, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342:253-257.
29. Rameh LE, Tolias KF, Duckworth BC, et al. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature. 1997;390:192-196.
30. Divecha N, Truong O, Hsuan JJ, et al. The cloning and sequence of the C isoform of PtdIns4P 5-kinase. Biochem J. 1995;309 (Pt 3):715-719.
31. Carricaburu V, Lamia KA, Lo E, et al. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation. Proc Natl Acad Sci US A. 2003;100:9867-9872.
32. Emerling BM, Hurov JB, Poulogiannis G, et al. Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors. Cell. 2013;155:844-857.